EcoDrugPlus

4-Hydroxyphenylpyruvate Dioxygenase B

Ensembl ID : ENSCARG00000051400
Gene Symbol: HPDB
1 Cross references
203 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSCARG00000062426
Gene Symbol: LOC113078042
3 Cross references
203 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSCARG00000043052
Gene Symbol: LOC113078042
3 Cross references
203 Possible Orthologues:

40s Ribosomal Protein S10

Ensembl ID : ENSCARG00000054802
Gene Symbol: LOC113050171
3 Cross references
318 Possible Orthologues:

40s Ribosomal Protein S11

Ensembl ID : ENSCARG00000037708
Gene Symbol: LOC113075571
3 Cross references
283 Possible Orthologues:

40s Ribosomal Protein S11

Ensembl ID : ENSCARG00000063323
Gene Symbol: LOC113075571
3 Cross references
283 Possible Orthologues:

40s Ribosomal Protein S12

Ensembl ID : ENSCARG00000011495
Gene Symbol: LOC113041442
3 Cross references
399 Possible Orthologues:

40s Ribosomal Protein S12

Ensembl ID : ENSCARG00000067795
Gene Symbol: LOC113065594
3 Cross references
398 Possible Orthologues:

40s Ribosomal Protein S13

Ensembl ID : ENSCARG00000017545
Gene Symbol: LOC113052051
3 Cross references
379 Possible Orthologues:

40s Ribosomal Protein S13

Ensembl ID : ENSCARG00000014307
Gene Symbol: LOC113052051
3 Cross references
378 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSCARG00000050668
Gene Symbol: LOC113038399
3 Cross references
328 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSCARG00000060831
Gene Symbol: LOC113038399
3 Cross references
326 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).